Oxytocin: Potential to mitigate cardiovascular risk

Area of Science:

• Endocrinology
• Cardiovascular Medicine
• Neuroscience

Background:

• Cardiovascular disease (CVD) is a leading global cause of mortality, with residual risk persisting despite current treatments.
• Oxidative stress and inflammation are critical contributors to atherosclerosis and CVD development.
• Novel therapeutic strategies are needed, particularly for patients intolerant to statins.

Purpose of the Study:

• To explore the potential of oxytocin as an ancillary treatment for cardiovascular disease (CVD).
• To review oxytocin's physiological effects relevant to CVD risk factors.
• To discuss oxytocin's role in CVD prevention and treatment.

Main Methods:

• Literature review of oxytocin's known functions and effects.
• Analysis of preclinical and clinical studies investigating oxytocin in atherosclerosis and related conditions.
• Examination of oxytocin's mechanism of action via its receptor in the vascular system.

Main Results:

• Oxytocin influences inflammation, weight gain, food intake, and insulin resistance.
• Studies suggest oxytocin may lower fat mass, cytokine levels, improve glucose tolerance, reduce blood pressure, and alleviate anxiety.
• Oxytocin plays a role in the gut-brain axis, relevant to obesity and type 2 diabetes.

Conclusions:

• Oxytocin possesses properties that make it a candidate for adjunctive CVD therapy.
• Its beneficial effects on multiple CVD risk factors warrant further investigation.
• Oxytocin may offer a novel therapeutic avenue for managing residual CVD risk.